AzTrials
AzTrials

Urinary RetentionRUC EHPADNCT03828968

Chronic Urinary Retention in Elderly Living in Homes for the Aged : Benefits of Bladder Scan Screening

A study testing bladder scan in people with Urinary Retention, run by Rennes University Hospital at 5 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this cross-sectional, multicentric and descriptive epidemiological study is to assess the prevalence of chronic urinary retention (CUR) in elderly living in residential care for dependent elderly people in order to determine if there is an interest in offering them a bladder scan screening. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Urinary Retention
What is being tested?
bladder scan
Could I receive a placebo?
No, everyone receives an active treatment
How many people
130 participants
Where
5 sitesFrance
Study dates
2 Feb 2019to 17 May 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adult people
  • Residents in a participating nursing home

Who cannot join

  • Resident with indwelling urinary catheter or regular urinary catheterisation
  • Resident or legal representative opposing participation

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

France5 sites
  • EHPAD du Centre Local Hospitalier de Saint-Joseph

    Combourg, 35270

  • EHPAD du Centre Hospitalier de Fougères

    Fougères, 35300

  • EHPAD Hôtel-Dieu

    Rennes, 35000

  • EHPAD de Saint-Brice-en-Coglès

    Saint-Brice-en-Coglès, 35460

  • EHPAD de Saint-Georges-de-Reintembault

    Saint-Georges-de-Reintembault, 35420

Other trials in France

About this study

The goal of this cross-sectional, multicentric and descriptive epidemiological study is to assess the prevalence of chronic urinary retention (CUR) in elderly living in residential care for dependent elderly people in order to determine if there is an interest in offering them a bladder scan screening.

Read the detailed description

The main goal of this study is to assess the prevalence of CUR in elderly living in homes for the aged, the secondary ones are to evaluate the risk factors and complications of CUR.

We will carry out this prevalence study in 5 centres whit a draw of 40 residents per centre. Following an information and a non-opposition of the patients, we will collect datas in their medical file (age, medical history and comorbidities, current treatments, anticholinergic score according to the ADS (Anticholinergic Drug Scale), GIR score according to the AGGIR scale (Autonomie Gérontologique Groupes Iso Ressources), FAC modified score (Functional Ambulation Classification modified), MMSE score (Mini Mental State Examination), communicative capacity, notion of fall and date of last fall, knowledge of urinary incontinence, knowledge of constipation, knowledge of previous urinary screening by bladder scan and previous urological consulting, last urinalysis and its results, last analysis of creatinemia and creatinine clearance according to CKD-EPI) and we will perform up to 3 measurements of vesical volume by bladder scan.

The expected results are a prevalence of CUR between 10 and 20 % among people living in homes for the aged with more urinary tract infections, renal insufficiency and falls in the CUR group showing the interest of screening for CUR by bladder scan in elderly people living in nursing homes according to risk groups based on the risk factors found.

Being tested
bladder scan
Keywords
urinary retention, chronic disease, aged, homes for the aged
Medical subject headings
Urinary Retention, Chronic Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • bladder scanDiagnostic test

    Measurement of vesical volume by bladder scan

Study groups in NCT03828968
Study groupRoleWhat they receive
Bladder scanOtherBladder scan performed on resident in homes for aged
Receives: Diagnostic Test: bladder scan

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Chronic urinary retention

    Chronic urinary retention definition : post-void residual urine > 250 mL twice without any clinical argument for acute urinary retention.

    Measured: 4 weeks after inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Feb 2019
  2. Study start2 Feb 2019
  3. Primary completion17 May 2019
  4. Study completion17 May 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
130 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03828968
Sponsor's protocol ID
35RC18_3063_RUC EHPAD
Acronym
RUC EHPAD
Status last verified
Apr 2023
First submitted
31 Jan 2019
Last updated
12 Apr 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing bladder scan in people with Urinary Retention, run by Rennes University Hospital at 5 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Chronic urinary retention (time frame: 4 weeks after inclusion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in